Next “Flagship” Offer: Healthcare Growth Engine Partnership™
From clear positioning to proven performance, your growth engine starts here.
One Integrated System to Prove ROI & Maximize Value
Most mid-market healthtech and pharmacy companies understand how to position themselves, but traction fades quickly if it’s not backed by measurable growth.
Marketing and sales stay siloed, making ROI unclear.
Boards and investors grow uneasy when revenue feels unpredictable.
Visibility stalls, allowing louder competitors to dominate the category conversation.
Valuation suffers because buyers pay for proven, scalable growth, not potential.
Deloitte’s 2025 U.S. Healthcare Executive Outlook¹ reports that 65% of healthcare executives list developing growth strategies as a top priority, and most say true growth requires an integrated, multidimensional approach, not one-off campaigns.
When positioning evolves into predictable revenue and valuation proof, everything changes:
Investor confidence rises.
Premium buyers take notice.
Growth becomes systematic, not scattered.
Our Healthcare Growth Engine Partnership™ is a 12-month commercialization system that turns early traction into predictable revenue, measurable ROI, and board-ready valuation proof without the cost of a full in-house growth team.
Don’t let your positioning lose momentum.
Accelerate Growth and Increase Enterprise Value
Positioning sets the stage, but sustainable growth is what convinces buyers, investors, and partners to pay a premium.
Our Healthcare Growth Engine Partnership gives you the leadership, systems, and proof points needed to scale revenue and enterprise value over the next 12 months without the cost and complexity of building a large internal team.
In 12 months, you'll gain:
Gain a clear path to higher valuation: A focused growth roadmap that shows where to invest time and budget to accelerate enterprise value.
Access top-level marketing leadership without the full-time hire: Fractional CMO expertise that guides strategy and execution without adding overhead.
Generate a steady flow of qualified opportunities: A demand and revenue engine that drives predictable pipeline growth and measurable ROI.
Build stronger market credibility: Thought leadership and positioning that make buyers, investors, and partners take notice.
Align your board and investors with confidence: Clear dashboards linking growth to valuation, keeping stakeholders focused and confident.
The outcome: measurable growth, predictable revenue, and a stronger enterprise value story that’s ready for the next raise, strategic partnership, or premium acquisition.
These aren’t abstract promises. One client doubled revenue and grew gross profit by 202% after working with Legacy DNA:
“Roxy and her team added consistency throughout our sales operations and brought a freshness we really needed in marketing. She’s not only a strategist, she’s a teacher who shows the why and how, helping our team execute with confidence. It’s had a tremendous impact.” — Dr. Steve Vo, CEO, BioPlus Specialty Pharmacy.
The 12-Month Growth System That Buyers & Investors Trust
We don’t just advise, we embed a repeatable growth infrastructure that directly ties GTM execution to valuation outcomes.
Commercialization Roadmap
We start by building a clear, board-ready roadmap that prioritizes the next year’s growth moves based on valuation impact.
Identify the highest-value customer segments and GTM opportunities.
Map pricing, channels, and adoption levers to drive predictable growth.
Sequence campaigns, launches, and demand plays for maximum traction.
Align sales and marketing execution with exit timing and milestones.
Fractional CMO Leadership
Most mid-market companies can’t justify a $300K+ CMO, but they desperately need that level of leadership. We embed an executive-level commercialization strategy that:
Guides your marketing & sales enablement teams.
Aligns messaging, campaigns, and sales tools with valuation metrics to ensure alignment.
Helps navigate investor expectations and board conversations.
Keeps your GTM machine accountable and focused.
You’ll have a strategic leader in the room without the full-time cost.
Demand + Revenue Engine
Buyers and investors don’t pay for potential; they pay for proven, scalable growth. We implement:
Targeted demand generation campaigns that attract your ideal customers.
Sales enablement tools to shorten cycles and increase close rates.
Pipeline acceleration plays that turn interest into revenue faster.
Measurement systems to link marketing efforts directly to enterprise value.
Your team will finally have a systematic way to generate, convert, and report growth.
Market Leadership Platform
Premium deals go to brands that own their category conversation. We help you:
Build a visible executive brand that buyers and investors respect.
Secure PR, speaking, and media opportunities aligned to your growth narrative.
Launch thought leadership campaigns that shape perception and market momentum.
Keep your CEO and leadership team top of mind for buyers long before the deal is on the table.
This isn’t vanity PR; it’s strategic visibility that increases valuation.
Valuation Dashboard
No more scrambling for metrics before board meetings or buyer calls. Our Valuation Dashboard gives you:
Clear visibility into revenue growth, adoption metrics, and retention.
Marketing ROI is tied directly to valuation impact.
Board/investor-ready quarterly updates that show measurable traction.
A living system to keep leadership, investors, and acquirers aligned.
When buyers come calling, you’ll already have the proof they need, packaged, credible, and ready.
From Market Potential to Market Power: Why CEOs Choose This Growth Engine
Growth isn’t just about more campaigns; it’s about proving your company matters.
Most mid-market healthtech and pharmacy leaders don’t fail because of weak technology. They stall because the market never fully understands or values what they’ve built. Legacy DNA was founded to change that.
We exist to bridge the gap between brilliant health innovations and the people who need them most. Too many breakthrough solutions end up in what we call the “zombie graveyard,” technically sound but commercially invisible. Our mission is to keep that from happening.
When you work with us, you get more than a marketing engine:
A commercialization partner who thinks like an acquirer: Every play we run reduces risk, proves market fit, and creates measurable enterprise value.
Leadership that has walked the path: Dr. Roxie Mooney, the only person with a doctorate in commercializing healthcare tech innovation, has helped launch over 100 innovations and contributed to multiple successful exits.
Systems that scale, not scattershot tactics: Our Growth Engine is a proven, repeatable framework that aligns marketing, sales enablement, demand generation, and board reporting into one valuation-focused system.
A purpose bigger than revenue: We believe every viable health tech innovation deserves to reach the market because when it does, lives change.
This isn’t about stacking more vendors or running more ads. It’s about building the market traction and proving buyers' demand while creating the impact you set out to make.
Frequently Asked Questions
-
Mid-market healthtech and pharmacy CEOs/founders are often PE-backed and need to scale revenue and prove valuation in the next 12–36 months.
-
Legacy DNA is a growth firm. We deliver commercialization science, not just campaigns. Our work connects GTM strategy, demand gen, sales enablement, and valuation reporting into one growth system.
-
A clear commercialization roadmap, early demand traction, and a live valuation dashboard showing ROI, as campaigns begin to fuel the pipeline.
-
No. We can partner with your existing team or help you execute with lean resources while providing fractional CMO leadership.
-
Sprints position you for exit and clarify your story. The Partnership turns that positioning into sustained growth and valuation proof over 12 months.
-
We track marketing and sales performance tied to valuation signals (growth, retention, expansion, category leadership). Everything connects back to enterprise value.
-
Yes. The same proof and traction that attract acquirers also strengthen investor confidence during capital raises.
-
We drive the process, but expect focused workshops and quarterly reviews. You stay informed and aligned without losing operational focus.
-
It’s a fixed-scope 12-month engagement, tailored to your growth goals and investor/board expectations without the full-time CMO overhead. -
Most CEOs begin with a 90-day Sprint. Once positioned, they graduate into this 12-month Partnership to execute, prove ROI, and maximize value.
Ready to Turn Positioning Into Measurable Growth & Valuation Power?
You’ve clarified your story. Now it’s time to prove it, scale it, and make buyers pay for it.
Start your Healthcare Growth Engine Partnership™ today and build the growth engine that keeps valuation climbing long before the exit table.
Secure your path to premium enterprise value.
This small, independent specialty pharmacy wanted to dance with the giants, but first, they needed to find their rhythm. Armed with stronger branding, positioning, and thought leadership, they learned new routines. It wasn’t long before they could jump on the dance floor and hustle their way to explosive growth (968% in one decade), taking their pharmacy from millions to billions.
Embracing a paradigm shift from traditional marketing, this tech platform undertook a comprehensive overhaul. Using more strategic go-to-market processes, they ushered their specialty pharmacy innovations into the modern era. Today, they continue to lead the way with their pioneering reputation and forge a path towards a more transformative future.
Armed with firsthand insights and feedback from numerous patients, this physician had a uniquely clear vision of the market's requirements. The problem was that he was up against a saturated landscape commanded by well-established household brands with deep pockets and enduring customer loyalty. The challenge lay in carving a distinctive niche. Leveraging a dynamic and robust commercialization strategy along with a bold brand identity, his product managed to not only capture the spotlight but also secure coveted shelf space within prominent big-box retailers.
It’s easy to coast along when you’re making a profit in an industry that’s full of growth and opportunity. But this independent pharmacy buying group wanted to take it to the next level. With a robust strategic marketing plan and by leveraging modern tools, tactics, and best practices, they were able to drive rapid growth and transform into an online destination for independent pharmacy owners.
With a lean team and limited resources, this company harnessed a late-entrant advantage, crafting an ingenious brand strategy that utilized a SaaS model and AI to creatively exploit the gaps left by dominant market players. The result? They were not only able to compete against industry giants, they went on to absorb their top competitor in just two years, reshaping the market landscape.
In an industry barreling toward commoditization, this specialty pharmacy recognized the urgency of setting itself apart. Through a blend of enhanced, strategic branding and impactful messaging, they were able to secure their market position in the hearts and minds of patients and stakeholders, making them a desirable target for acquisition.
This specialty pharmacy built a strong name for itself in the HCV field - but struggled to stay visible in a saturated market. Leadership knew marketing resources were stretched thin, and they had no real strategic plan in place, but the market was experiencing massive growth. Capitalizing on that growth meant they needed a plan - a marketing plan. Two years later, with a strategic marketing plan and enhanced foundational assets in place, their net worth soared from $50 million to $500 million, making them an irresistible acquisition for the fifth-largest pharmacy in the United States.
This digital health startup set out to develop an early adoption strategy and a clear path to market. While developing the strategies that would help them avoid pitfalls, circumvent failure, and recognize opportunities, COVID hit. Armed with their newly acquired early adoption vision, they were able to confidently perform a powerful pandemic pivot to success.
